Stock ANTRIABIO INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar AntriaBio Inc OTC Bulletin Board

Equities

US0372301095

End-of-day quote OTC Bulletin Board
Other stock markets
- USD - Intraday chart for AntriaBio Inc
22/05 Traders Cautious Ahead of Fed Minutes, Nvidia Earnings, Stifling US Equity Futures Pre-Bell MT
22/05 Top Premarket Gainers MT

Chart calendar AntriaBio Inc

b778f5dc.p7GjzjBT2fhLyUOrJSE0LjQc_oxNN5UJcd_C_sN15Cw.8Nr6pHQKrqAOoyvNfBZlVlFbyOkCBt5WNpe3jq0-thzr6NGlRjutkxnwdw~4aabe53377c14a6259393da14b28f935

Upcoming events on AntriaBio Inc

06/06/2024 10:30 pm Jefferies Global Healthcare Conference
12/09/2024 Q4 2024 Earnings Release (Projected)
07/11/2024 Q1 2025 Earnings Release (Projected)
05/02/2025 Q2 2025 Earnings Release (Projected)
20/05/2025 Q3 2025 Earnings Release (Projected)

Past events on AntriaBio Inc

22/05/2024 03:00 am RZ402-201 Phase 2 Study Results Call
17/05/2024 03:30 am Annual General Meeting
16/05/2024 01:35 am Q3 2024 Earnings Release
14/05/2024 10:00 pm JMP Securities Life Sciences Conference
04/05/2024 10:45 pm Pediatric Endocrine Society Meeting - Abstract No : 6790
14/02/2024 02:35 am Q2 2024 Earnings Release
28/11/2023 01:00 am BTIG Ophthalmology Day
14/11/2023 02:35 am Q1 2024 Earnings Release
26/09/2023 11:40 pm Cantor Global Healthcare Conference
15/09/2023 01:35 am Q4 2023 Earnings Release
12/09/2023 11:30 pm H.C. Wainwright Global Investment Conference
28/06/2023 02:00 am RZ358 Phase3 Update Call
26/05/2023 03:30 am Annual General Meeting
12/05/2023 01:35 am Q3 2023 Earnings Release
23/03/2023 02:00 am Investor Meeting - Key Opinion Leader
11/02/2023 02:35 am Q2 2023 Earnings Release
17/11/2022 09:55 pm Jefferies London Healthcare Conference
10/11/2022 02:35 am Q1 2023 Earnings Release
03/11/2022 11:17 pm Retina Society Scientific Meeting
16/09/2022 01:35 am FY 2022 Earnings Release

Annual results

Fiscal PeriodGiugno 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBITDA
Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-25,9
-31,3
17.11%		0,00
0,00
- 		-22,9
-22,5
-1.68%		-41,8
-45,1
7.27%		-56,0
-60,0
6.65%
-66,2

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-30,4
-35,8
14.96%		0,00
0,00
- 		-20,9
-22,1
5.26%		-41,1
-46,7
12.08%		-51,8
-58,0
10.74%
-63,6

Net income
Million USD		Released
Forecast
Spread 		-30,4
-35,8
14.96%		-20,3
-21,8
6.73%		-20,9
-21,6
3.15%		-41,1
-46,7
12.08%		-51,8
-57,8
10.46%
-63,8

EPS
USD		Released
Forecast
Spread 		-18,5
-15,0
-23.33%		-3,54
-4,00
11.5%		-2,72
-2,82
3.63%		-2,26
-2,48
8.99%		-1,01
-1,22
17.35%
-1,17

Announcement Date10/09/1913/10/2015/09/2115/09/2214/09/23-

Quarterly results

Fiscal PeriodGiugno 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00


0,00


0,00


0,00


28,8

EBIT
Million USD		Released
Forecast
Spread 		-10,8
-15,5
30.66%		-11,3
-14,6
22.58%		-10,2
-12,2
16.06%		-14,4
-15,5
7.41%		-17,1
-15,7
-8.84%		-14,2
-18,2
21.82%		-15,9
-16,5
3.52%		-15,2
-18,1
15.94%		-16,2
-16,8
3.69%
-18,3


-18,0


-19,2


-20,4


36,4

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-11,2
-16,2
30.67%		-9,42
-15,1
37.5%		-9,83
-12,4
20.86%		-13,6
-13,5
-0.27%		-15,7
-15,6
-0.51%		-12,7
-18,5
31.21%		-14,5
-16,4
11.25%		-13,9
-16,7
16.57%		-17,1
-16,2
-4.93%
-18,7


-18,0


-19,2


-20,4


36,4

Net income
Million USD		Released
Forecast
Spread 		-11,2
-15,9
29.62%		-9,42
-15,1
37.5%		-9,83
-12,4
20.86%		-13,6
-13,5
-0.27%		-15,7
-15,6
-0.51%		-12,7
-18,5
31.21%		-14,5
-13,5
-7.86%		-13,9
-16,9
17.58%		-17,1
-16,2
-4.93%
-18,7


-18,0


-19,2


-20,4


36,4

EPS
USD		Released
Forecast
Spread 		-0,65
-0,91
28.26%		-0,30
-0,56
45.95%		-0,19
-0,31
39.36%		-0,26
-0,32
18.24%		-0,30
-0,30
0%		-0,25
-0,36
29.78%		-0,28
-0,28
0.88%		-0,27
-0,29
6.9%		-0,34
-0,30
-11.74%
-0,31


-0,29


-0,28


-0,27


0,13

Announcement Date12/05/2215/09/2209/11/2210/02/2311/05/2314/09/2313/11/2313/02/2415/05/24-----

Upcoming sector events for AntriaBio Inc

24/07/2024 VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
25/07/2024 BIOCON LIMITED: Q1 2025 Earnings Release (Projected)
25/07/2024 10:30 am ARGENX SE: Q2 2024 Earnings Release
30/07/2024 RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024 CASSAVA SCIENCES, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024 SPRINGWORKS THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024 XENCOR, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024 SAREPTA THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
More events

Past sector events for AntriaBio Inc

17/05/2024 04:30 pm AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release
16/05/2024 05:16 pm BIOCON LIMITED: Q4 2024 Earnings Release
16/05/2024 10:30 am ZEALAND PHARMA A/S: Q1 2024 Earnings Release
16/05/2024 LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release
15/05/2024 05:35 pm THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release
15/05/2024 04:30 pm CABALETTA BIO, INC.: Q1 2024 Earnings Release
15/05/2024 TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release
15/05/2024 01:35 am ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release
15/05/2024 01:30 am ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release
14/05/2024 05:30 pm IMMUNOME, INC.: Q1 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. RZLT Stock
  4. Stock
  5. Calendar AntriaBio Inc